BI
BVF Inc Portfolio holdings
AUM
$2.8B
This Quarter Return
-18.74%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$404M
AUM Growth
+$404M
(-31%)
Cap. Flow
+$21M
Cap. Flow
% of AUM
5.19%
Top 10 Holdings %
Top 10 Hldgs %
67.69%
Holding
33
New
3
Increased
15
Reduced
4
Closed
1
Top Buys
| 1 |
Esperion Therapeutics
ESPR
|
$10.3M |
| 2 |
Cytokinetics
CYTK
|
$10M |
| 3 |
CPXX
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
|
$8.82M |
| 4 |
CNCE
Concert Pharmaceuticals, Inc.
CNCE
|
$7.15M |
| 5 |
BPMC
Blueprint Medicines
BPMC
|
$6.53M |
Top Sells
| 1 |
LOXO
Loxo Oncology, Inc
LOXO
|
$17.4M |
| 2 |
Ironwood Pharmaceuticals
IRWD
|
$12.9M |
| 3 |
FPRX
Five Prime Therapeutics, Inc.
FPRX
|
$12.5M |
| 4 |
CytomX Therapeutics
CTMX
|
$35K |
| 5 |
CALA
Calithera Biosciences, Inc
CALA
|
$28.4K |
Sector Composition
| 1 | Healthcare | 64.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Savara
SVRA
$572M
| $1.01M | 0.25% |
3,696,961
| – | – |
|
|
CALA
27
DELISTED
Calithera Biosciences, Inc
CALA
| $925K | 0.23% |
162,900
-5,000
| -3% | -$28.4K |
|
|
VXRT
28
DELISTED
Vaxart
VXRT
| $526K | 0.13% |
350,776
| – | – |
|
|
RXDX
29
DELISTED
Ignyta, Inc.
RXDX
| $339K | 0.08% |
+50,000
| New | +$339K |
|
|
NRX
30
DELISTED
NEPHROGENEX INC COM
NRX
| $184K | 0.05% |
392,156
| – | – |
|
|
FPRX
31
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| – | – |
-300,000
| Closed | -$12.5M |
|